Skip to search formSkip to main contentSkip to account menu

parecoxib sodium

Known as: N-(((5-methyl-3-phenylisoxazol-4-yl)-phenyl)sulfonyl)propanamine, sodium salt, Propanamide, N-((4-(5-methyl-3-phenyl-4- isoxazolyl)phenyl)sulfonyl)-, Sodium Salt 
A water-soluble, injectable sodium salt form of parecoxib, an amide prodrug of the cyclooxygenase II (COX-2) selective, non-steroidal anti… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Objectives To evaluate the morphine-sparing effects of the sequential treatment versus placebo in subjects undergoing total knee… 
2019
2019
Background This study aimed to investigate the effectiveness of perioperative parecoxib sodium combined with transversus… 
Review
2017
Review
2017
Objectives To characterise the use of the parenteral non-steroidal anti-inflammatory drug parecoxib when given by continuous… 
2016
2016
Introduction Total knee arthroplasty (TKA) has been regarded as a most painful orthopaedic surgery. Although many surgeons… 
2015
2015
OBJECTIVE To discuss the effect of preemptive analgesia with parecoxib sodium in patients undergoing radical resection of lung… 
2005
2005
The newly injectable cyclooxygenase-2 selective nonsteroidal antiinflammatory drug, parecoxib, has never been compared with… 
Review
2005
Review
2005
At the end of September 2004, Merck & Co announced the voluntary withdrawal of rofecoxib (Vioxx) worldwide because of an… 
Review
2004
Review
2004
OBJECTIVE To review the pharmacology, pharmacokinetics, clinical efficacy and safety studies, adverse effects, drug interactions…